United States · FDA National Drug Code directory
capmatinib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66828-0317_34b3bbb2-c335-4290-b1d5-13f9c415aa5d
- Product NDC
- 66828-0317
- Form
- TABLET, FILM COATED
- Composition / generic term
- capmatinib
- Labeler
- Novartis Pharma Produktions GmbH
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20200506
- Source listing expiry
- 20261231
Source-listed ingredients
- CAPMATINIB HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 25000 TABLET, FILM COATED in 1 DRUM (66828-0317-1) · 66828-0317-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →